CELYNTRA THERAPEUTICS
De berekende faillissementskans van CELYNTRA THERAPEUTICS over 12 maanden bedraagt 1,3% (laag). Het bedrijf is actief sinds 2019 en het Belgisch Staatsblad bevat geen insolventie- of waarschuwingssignalen. Er zijn geen verwerkte jaarrekeningcijfers beschikbaar; deze conclusie steunt uitsluitend op register- en Staatsbladgegevens.
| Actief | 6 jaar |
| Bestuur | 1 |
| Vestigingen | 1 |
| Publicaties | 12 |
Statistische inschatting op basis van openbare bronnen — geen kredietadvies of vaststelling. Hoe berekenen we dit?
| Boekjaar | Type | Neerlegging | Referentie |
|---|---|---|---|
| 31-12-2025 | volledig | 10-06-2026 | 2026-00150073 |
| 31-12-2024 | volledig | 16-10-2025 | 2025-00543890 |
| 31-12-2023 | volledig | 24-07-2024 | 2024-00293670 |
| 31-12-2022 | volledig | 30-06-2023 | 2023-00179017 |
| 31-12-2021 | volledig | 23-09-2022 | 2022-20436329 |
| 31-12-2020 | volledig | 30-09-2021 | 2021-69300251 |
| 31-12-2019 | volledig | 30-07-2020 | 2020-36800014 |
-
Actief05-03-2026 → heden
Voormalige bestuurders (2)
-
Voormalig07-06-2024 → 05-03-2026
2 gebeurtenissen
- 05-03-2026 Ontslagen· Bestuurder
- 07-06-2024 Benoemd· Bestuurder
-
Voormalig— → 07-06-2024
| Commissaris / bedrijfsrevisor | IBR/IRE-nummer | Periode |
|---|---|---|
| PwC Réviseurs d'Entreprises SRLActief Commissaris · vertegenwoordigd door Romain Seffer |
— | 21-06-2022 → heden |
| BDO Réviseurs d'Entreprises SRL Commissaris · vertegenwoordigd door Gert Claes |
— | — → 01-01-2022 |
| NACE primair | Groothandel(46460) |
| Rechtsvorm | NV(014) |
| Oprichtingsdatum | 19-11-2019 |
| Status | Actief |
| Postcode | 1435 |
Eén tijdlijn van alles wat er met dit bedrijf is gebeurd — publicaties, insolventie- en levensloopgebeurtenissen, administratieve wijzigingen en neergelegde jaarrekeningen.
12-06-2026 Publicatie in het Belgisch Staatsblad — Kleine wijziging
Technische details
{
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2026-06-12",
"filing_date": "2026-06-02",
"act_kind_objet": "Renouvellement mandat commissaire - Pouvoirs sp\u00E9ciaux"
},
"decision": {
"body": "enig_aandeelhouder_schriftelijk",
"date": "2026-03-05",
"unanimous": true
},
"agm_change": null,
"detected_kind": "mandate_renewal",
"other_address": null,
"mandate_renewal": {
"period_end": null,
"mandate_kind": "commissaire",
"period_start": null,
"remuneration_eur": null,
"remuneration_kind": null,
"person_or_entity_kbo": null,
"person_or_entity_name": "PwCReviseurs d\u0027Entreprises SRL"
},
"subject_company": {
"kbo": "0737.829.015",
"name_full": "Celyntra Therapeutics",
"legal_form": "SA"
},
"accounts_deposit": {
"filing_kind": null,
"fiscal_year_end": "2027-12-31",
"filing_reference": null
},
"publication_proxy": {
"kind": "org",
"org_kbo": null,
"org_name": "AKD SRL",
"person_name": "Pieter De Vos",
"org_rep_person_name": "Pieter De Vos"
},
"co_filed_documents": [],
"fiscal_year_change": null,
"liquidation_closure": null,
"officer_designation": null,
"special_procuration": {
"grantee_kbo": null,
"grantee_name": "Mr. C\u00E9dric Darcis",
"grantor_name": "Celyntra Therapeutics",
"scope_summary": "To perform all necessary steps and sign all necessary documents for the publication of the preceding resolutions in the Annexes of the Moniteur belge and to make any useful or necessary steps related to it.",
"monetary_cap_eur": null,
"scope_categories": [
"publication"
],
"termination_clause": null,
"substitution_allowed": true
},
"is_volet_a_only_stub": false,
"vakbekwaamheid_change": null,
"should_reroute_to_category": null,
"single_shareholder_declaration": {
"art_csa": null,
"effective_date": "2026-03-05",
"shareholder_kbo": null,
"shareholder_name": null
}
}07-05-2026 4 bestuurders benoemd, 1 ontslagnemend
- Jason Conner — Bestuurder
- Timothy Speelman — Délégé
- Charlotte Vanham — Délégé
- Pieter De Vos — Délégé
- Gustavo Mahler — Bestuurder
Technische details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Gustavo Mahler",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": "de_plein_droit_dissolution",
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "L\u0027Actionnaire accepte et confirme, pour autant que de besoin, la d\u00E9mission de M. Gustavo Mahler en tant qu\u0027administrateur de la Soci\u00E9t\u00E9 avec effet imm\u00E9diat.",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Jason Conner",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": false,
"effective_date": null,
"evidence_quote": "L\u0027Actionnaire nomme M. Jason Conner, \u00E9lisant domicile au si\u00E8ge de la Soci\u00E9t\u00E9 pour les besoins de son mandat, comme administrateur unique de la Soci\u00E9t\u00E9 avec effet imm\u00E9diat pour une dur\u00E9e de six ans.",
"decharge_status": null,
"mandate_duration": {
"kind": "n_years",
"value": 6
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
},
{
"kind": "decharge_granted",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Jason Conner",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "M. Jason Conner signe les pr\u00E9sentes r\u00E9solutions pour accepter le mandat d\u0027administrateur de la Soci\u00E9t\u00E9 et d\u00E9clarer qu\u0027il n\u0027est pas emp\u00EAch\u00E9 d\u0027exercer le mandat d\u0027administrateur en vertu d\u0027une interdiction d\u0027exercer",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "delegation_dagelijks_bestuur_in",
"role": "d\u00E9l\u00E9g\u00E9",
"person": {
"rrn": null,
"name": "Timothy Speelman",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "additional",
"via_org": {
"kbo": null,
"name": "AKD SRL",
"address": "place du Champ de Mars 5, 1050 Ixelles",
"country": "BE",
"legal_form": "SRL"
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "L\u0027Actionnaire donne procuration, avec facult\u00E9 de substitution, \u00E0 M. Timothy Speelman, Mile. Charlotte Vanham et/ou M. Pieter De Vos, \u00E9lisant domicile chez AKD SRL, place du Champ de Mars 5, 1050 Ixelles. Belgique, avec pouvoir d\u0027agir ensemble ou s\u00E9par\u00E9ment, aux fins d\u0027effectuer, au nom et pour le co",
"decharge_status": null,
"mandate_duration": {
"kind": "indefinite",
"value": null
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "delegation_dagelijks_bestuur_in",
"role": "d\u00E9l\u00E9g\u00E9",
"person": {
"rrn": null,
"name": "Charlotte Vanham",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "additional",
"via_org": {
"kbo": null,
"name": "AKD SRL",
"address": "place du Champ de Mars 5, 1050 Ixelles",
"country": "BE",
"legal_form": "SRL"
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "L\u0027Actionnaire donne procuration, avec facult\u00E9 de substitution, \u00E0 M. Timothy Speelman, Mile. Charlotte Vanham et/ou M. Pieter De Vos, \u00E9lisant domicile chez AKD SRL, place du Champ de Mars 5, 1050 Ixelles. Belgique, avec pouvoir d\u0027agir ensemble ou s\u00E9par\u00E9ment, aux fins d\u0027effectuer, au nom et pour le co",
"decharge_status": null,
"mandate_duration": {
"kind": "indefinite",
"value": null
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "delegation_dagelijks_bestuur_in",
"role": "d\u00E9l\u00E9g\u00E9",
"person": {
"rrn": null,
"name": "Pieter De Vos",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "additional",
"via_org": {
"kbo": null,
"name": "AKD SRL",
"address": "place du Champ de Mars 5, 1050 Ixelles",
"country": "BE",
"legal_form": "SRL"
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "L\u0027Actionnaire donne procuration, avec facult\u00E9 de substitution, \u00E0 M. Timothy Speelman, Mile. Charlotte Vanham et/ou M. Pieter De Vos, \u00E9lisant domicile chez AKD SRL, place du Champ de Mars 5, 1050 Ixelles. Belgique, avec pouvoir d\u0027agir ensemble ou s\u00E9par\u00E9ment, aux fins d\u0027effectuer, au nom et pour le co",
"decharge_status": null,
"mandate_duration": {
"kind": "indefinite",
"value": null
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2026-05-07",
"filing_date": "2026-03-05",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decisions": [
{
"body": "enig_aandeelhouder_schriftelijk",
"date": "2026-03-05",
"unanimous": true
}
],
"is_correction": false,
"subject_company": {
"kbo": "0737.829.015",
"name_full": "Celyntra Therapeutics",
"legal_form": "SA"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Charlotte Vanham",
"org_rep_person_name": null,
"person_role_at_subject": "Mandataire"
},
"co_filed_documents": [],
"corrected_publication_numac": null
}07-05-2026 1 bestuurder benoemd, 1 ontslagnemend
- Jason Conner — Bestuurder
- Gustavo Mahler — Bestuurder
Technische details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Gustavo Mahler",
"address": null,
"birth_date": null
},
"effective_date": "2026-03-05",
"evidence_quote": "L\u0027Actionnaire accepte et confirme, pour autant que de besoin, la d\u00E9mission de M. Gustavo Mahler en tant qu\u0027administrateur de la Soci\u00E9t\u00E9 avec effet imm\u00E9diat."
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Jason Conner",
"address": null,
"birth_date": null
},
"effective_date": "2026-03-05",
"evidence_quote": "L\u0027Actionnaire nomme M. Jason Conner, \u00E9lisant domicile au si\u00E8ge de la Soci\u00E9t\u00E9 pour les besoins de son mandat, comme administrateur unique de la Soci\u00E9t\u00E9 avec effet imm\u00E9diat pour une dur\u00E9e de six ans."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0737.829.015",
"name_full": "CELYNTRA THERAPEUTICS",
"legal_form": "SA"
}
}26-08-2024 2 bestuurders benoemd, 1 ontslagnemend
- Gustavo Mahler — Bestuurder
- Cédric Darcis — Dagelijks bestuur
- Stefan Braam — Bestuurder
Technische details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Stefan Braam",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": "de_plein_droit_dissolution",
"subkind": null,
"via_org": null,
"statutory": "statutair",
"compensated": null,
"effective_date": "2024-06-07",
"evidence_quote": "La d\u00E9mission de M. Stefan Braam en tant qu\u0027administrateur unique de la soci\u00E9t\u00E9 avec effet au 7 juin 2024 est, pour autant que de besoirn, accept\u00E9e et confirm\u00E9e.",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Gustavo Mahler",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": "statutair",
"compensated": false,
"effective_date": "2024-06-07",
"evidence_quote": "L\u0027actionnaire nomme M. Gustavo Mahler, \u00E9lisar\u0131t domicile au si\u00E8ge de la soci\u00E9t\u00E9 pour les besoins de sori mandat, en tant qu\u0027administrateur unique de la soci\u00E9t\u00E9 pour une dur\u00E9e ind\u00E9termin\u00E9e \u00E0 compter du 7 juin 2024.",
"decharge_status": null,
"mandate_duration": {
"kind": "indefinite",
"value": null
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
},
{
"kind": "delegation_dagelijks_bestuur_in",
"role": "dagelijks_bestuur",
"person": {
"rrn": null,
"name": "C\u00E9dric Darcis",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": {
"kbo": null,
"name": "AKD SRL",
"address": "place du Champ de Mars 5, 1050 Ixelles",
"country": "BE",
"legal_form": "SRL"
},
"statutory": "statutair",
"compensated": null,
"effective_date": null,
"evidence_quote": "L\u0027actionnaire donrie procuration, avec facult\u00E9 de substitution, \u00E0 Mr. C\u00E9dric Darcis, \u00E9lisar\u0131t domicile au si\u00E8ge de la soci\u00E9t\u00E9, Mme Nathalie Locht et/ou M. Timothy Speelman et/ou M. Pieter De Vos, \u00E9lisant domicile chez AKD SRL, place du Champ de Mars 5, 1050 Ixelles, Belgique, avec pouvoir d\u0027agir ens",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": "2024-08-26",
"filing_date": "2024-06-07",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decisions": [
{
"body": "enig_aandeelhouder_schriftelijk",
"date": "2024-06-07",
"unanimous": null
}
],
"is_correction": false,
"subject_company": {
"kbo": "0737.829.015",
"name_full": "Celyntra Therapeutics",
"legal_form": "SA"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Nathalie Locht",
"org_rep_person_name": null,
"person_role_at_subject": "Mandataire"
},
"co_filed_documents": [],
"corrected_publication_numac": null
}26-08-2024 1 bestuurder benoemd, 1 ontslagnemend
- Gustavo Mahler — Bestuurder
- Stefan Braam — Bestuurder
Technische details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Stefan Braam",
"address": null,
"birth_date": null
},
"effective_date": "2024-06-07",
"evidence_quote": "La d\u00E9mission de M. Stefan Braam en tant qu\u0027administrateur unique de la soci\u00E9t\u00E9 avec effet au 7 juin 2024 est, pour autant que de besoirn, accept\u00E9e et confirm\u00E9e."
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Gustavo Mahler",
"address": null,
"birth_date": null
},
"effective_date": "2024-06-07",
"evidence_quote": "L\u0027actionnaire nomme M. Gustavo Mahler, \u00E9lisar\u0131t domicile au si\u00E8ge de la soci\u00E9t\u00E9 pour les besoins de sori mandat, en tant qu\u0027administrateur unique de la soci\u00E9t\u00E9 pour une dur\u00E9e ind\u00E9termin\u00E9e \u00E0 compter du 7 juin 2024."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0737.829.015",
"name_full": "CELYNTRA THERAPEUTICS",
"legal_form": "SA"
}
}20-09-2023 Kapitaalverhoging van €2.100.000 tot €2.161.500
- €61.500 → €2.161.500
- 2 kapitaalbewegingen in deze akte
Technische details
{
"events": [
{
"kind": "capital_increase",
"amount": 2100000.0,
"currency": "EUR",
"after_eur": 2161500.0,
"delta_eur": 2100000.0,
"before_eur": 61500.0,
"amount_type": "kapitaal_effectief",
"effective_date": "2023-09-04",
"evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide d\u2019augmenter le capital par un apport en num\u00E9raire d\u0027un montant de deux millions cent mille euros (\u20AC 2.100.000,00) pour porter le capital de soixante et un mille cinq cents euros (\u20AC 61.500,00) \u00E0 deux millions cent soixante et un mille cinq cents euros (\u20AC 2.161.500,00) sans cr\u00E9ation de nouvelles actions.",
"contribution_type": "cash"
},
{
"kind": "capital_decrease",
"amount": 1809200.0,
"currency": "EUR",
"after_eur": 352300.0,
"delta_eur": -1809200.0,
"before_eur": 2161500.0,
"amount_type": "kapitaal_effectief",
"effective_date": "2023-09-04",
"evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide de r\u00E9duire formellement le capital \u00E0 concurrence d\u2019un million huit cent neuf mille deux cents euros (\u20AC 1.809.200,00), pour ramener le capital de deux millions cent soixante et un mille cinq cents euros (\u20AC 2.161.500,00) \u00E0 trois cent cinquante-deux mille trois cents euros (\u20AC 352.300,00), par l\u0027absorption des pertes subies",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0737.829.015",
"name_full": "CELYNTRA THERAPEUTICS",
"legal_form": "SA"
}
}20-09-2023 Kapitaalverhoging van €2.100.000 tot €2.161.500
- €61.500 → €2.161.500
- 2 kapitaalbewegingen in deze akte
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 2161500.0,
"delta_eur": 2100000.0,
"before_eur": 61500.0,
"subscribers": [
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "Ncardia Holding",
"share_class": null,
"liberation_pct": 100.0,
"contribution_kind": "numeraire",
"n_shares_subscribed": null,
"contribution_amount_eur": 2100000.0
}
],
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": "numeraire",
"paid_up_delta_eur": 2100000.0,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_decrease",
"after_eur": 352300.0,
"delta_eur": -1809200.0,
"before_eur": 2161500.0,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": "loss_absorption",
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": "Gewone Aandelen",
"n_new_shares": 100,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "statutory_reserve_release",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": "convert_to_distributable"
}
],
"notary": {
"name": "Paul MASELIS",
"firm_city": null,
"firm_name": "MASELIS \u0026 DEVRIESE, Notaires Associ\u00E9s",
"office_city": "Schaerbeek",
"is_associated": true
},
"act_meta": {
"language": "fr",
"pub_date": "2023-09-20",
"filing_date": "2023-09-18",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "assembl\u00E9e_generale_extraordinaire",
"act_date": "2023-09-08",
"unanimous": true,
"under_authorized_capital": false,
"underlying_resolution_date": null
},
"bedrijfsrevisor": {
"waived": true,
"firm_kbo": null,
"firm_name": null,
"ibr_number": null,
"mission_type": null,
"individual_name": null
},
"subject_company": {
"kbo": "0737.829.015",
"name_full": "CELYNTRA THERAPEUTICS",
"legal_form": "Soci\u00E9t\u00E9 anonyme",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"expedition du proc\u00E8sverbal",
"procuration",
"statuts coordonn\u00E9s"
],
"shareholders_after": [
{
"kbo": null,
"pct": null,
"kind": "org",
"name": "Ncardia Holding",
"role": "aandeelhouder",
"n_shares": null,
"share_class": null
}
],
"share_classes_after": [
{
"n_shares": 100,
"class_name": "Gewone Aandelen",
"capital_share_eur": 352300.0,
"voting_rights_per_share": 1.0
}
]
}31-03-2023 Zetelverplaatsing van Gosselies naar Mort-Saint-Guibert
- Rue Adrienne Bolland 47, 6041 Gosselies → 1435 Mort-Saint-Guibert, rue Edouard Belin 2
Technische details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "siege_social",
"new_address": {
"raw": "1435 Mort-Saint-Guibert, rue Edouard Belin 2",
"city": "Mort-Saint-Guibert",
"region": "waals_gewest",
"street": "Edouard Belin",
"country": "BE",
"postcode": "1435",
"box_number": null,
"street_number": "2",
"locality_suffix": null
},
"old_address": {
"raw": "Rue Adrienne Bolland 47, 6041 Gosselies",
"city": "Gosselies",
"region": "waals_gewest",
"street": "Adrienne Bolland",
"country": "BE",
"postcode": "6041",
"box_number": null,
"street_number": "47",
"locality_suffix": null
},
"effective_date": "2023-03-01",
"evidence_quote": "L\u0027administrateur d\u00E9cide de transf\u00E9rer le si\u00E8ge de la soci\u00E9t\u00E9 de 6041 Gosselies, rue Adrienne Bolland 47 \u00E0 1435 Mort-Saint-Guibert, rue Edouard Belin 2 \u00E0 partir du 1er mars 2023.",
"region_changed": false,
"is_statute_change": true,
"nationality_change": false,
"old_address_source": "act_body",
"statute_clause_text": null,
"statute_article_number": null,
"effective_date_qualifier": "absolute",
"statutaire_vs_werkelijke": "statutaire",
"linguistic_region_changed": false,
"court_jurisdiction_changed": false,
"effective_date_is_approximate": false
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": "2023-03-31",
"filing_date": "2023-03-22",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "enig_aandeelhouder_schriftelijk",
"date": "2023-03-06",
"unanimous": true
},
"subject_company": {
"kbo": "0737.829.015",
"name_full": "Celyntra Therapeutics",
"legal_form": "SA"
},
"publication_proxy": {
"kind": "org",
"org_kbo": null,
"org_name": "AKD SRL",
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": []
}31-03-2023 Zetelverplaatsing van Gosselies naar Mort-Saint-Guibert
- rue Adrienne Bolland 47, 6041 Gosselies → rue Edouard Belin 2, 1435 Mort-Saint-Guibert
Technische details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "statutaire",
"new_address": {
"city": "Mort-Saint-Guibert",
"region": null,
"street": "rue Edouard Belin",
"country": "BE",
"postcode": "1435",
"box_number": null,
"street_number": "2"
},
"old_address": {
"city": "Gosselies",
"region": null,
"street": "rue Adrienne Bolland",
"country": "BE",
"postcode": "6041",
"box_number": null,
"street_number": "47"
},
"effective_date": "2023-03-01",
"evidence_quote": "L\u0027administrateur d\u00E9cide de transf\u00E9rer le si\u00E8ge de la soci\u00E9t\u00E9 de 6041 Gosselies, rue Adrienne Bolland 47 \u00E0 1435 Mort-Saint-Guibert, rue Edouard Belin 2 \u00E0 partir du 1er mars 2023."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0737.829.015",
"name_full": "CELYNTRA THERAPEUTICS",
"legal_form": "SA"
}
}21-06-2022 1 bestuurder benoemd, 1 ontslagnemend
- Romain Seffer — Commissaris
- Gert Claes — Commissaris
Technische details
{
"events": [
{
"kind": "commissaris_out",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Gert Claes",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "BDO Reviseurs d\u0027Entreprises SRL",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2022-01-01",
"evidence_quote": "L\u0027administrateur a pris note du fait que BDO Reviseurs d\u0027Entreprises SRL, le commissaire de la soci\u00E9t\u00E9, a d\u00E9cid\u00E9 de remplacer No\u00EBlle Lucas en tant que repr\u00E9sentant l\u00E9gal par Gert Claes \u00E0 partir du 1 janvier 2022"
},
{
"kind": "commissaris_in",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Romain Seffer",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "PwC Reviseurs d\u0027Entreprises SRL",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "L\u0027actionnaire a d\u00E9cid\u00E9 de nommer PwC Reviseurs d\u0027Entreprises SRL, ayant son si\u00E8ge \u00E0 1831 Diegem, Culliganlaan 5, comme commissaire pour un terme de trois ans. PwC Reviseurs d\u0027Entreprises SRL a d\u00E9sign\u00E9 M. Romain Seffer, r\u00E9viseur d\u0027entreprises, pour la repr\u00E9senter et le charge de l\u0027exercice de ce mand"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0737.829.015",
"name_full": "CELYNTRA THERAPEUTICS",
"legal_form": "SA"
}
}21-06-2022 5 bestuurders benoemd, 1 ontslagnemend
- Romain Seffer — Commissaris
- Nathalie Locht — Delegé
- Timothy Speelman — Delegé
- Nathalie Locht — Delegé
- Timothy Speelman — Delegé
- Noëlle Lucas — Commissaris
Technische details
{
"events": [
{
"kind": "commissaris_out",
"role": "commissaris",
"person": {
"rrn": null,
"name": "No\u00EBlle Lucas",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": "statutair",
"compensated": null,
"effective_date": "2022-01-01",
"evidence_quote": "a d\u00E9cid\u00E9 de remplacer No\u00EBlle Lucas en tant que repr\u00E9sentant l\u00E9gal par Gert Claes \u00E0 partir du 1 janvier 2022",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "commissaris_in",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Romain Seffer",
"address": null,
"birth_date": null,
"profession": "r\u00E9viseur d\u0027entreprises",
"birth_place": null
},
"reason": null,
"subkind": "renewal",
"via_org": {
"kbo": null,
"name": "PwC Reviseurs d\u0027Entreprises SRL",
"address": "1831 Diegem, Culliganlaan 5",
"country": "BE",
"legal_form": "SRL"
},
"statutory": "statutair",
"compensated": null,
"effective_date": null,
"evidence_quote": "L\u0027actionnaire a d\u00E9cid\u00E9 de nommer PwC Reviseurs d\u0027Entreprises SRL, ayant son si\u00E8ge \u00E0 1831 Diegem, Culliganlaan 5, comme commissaire pour un terme de trois ans.",
"decharge_status": null,
"mandate_duration": {
"kind": "n_years",
"value": "3"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "delegation_dagelijks_bestuur_in",
"role": "deleg\u00E9",
"person": {
"rrn": null,
"name": "Nathalie Locht",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": {
"kbo": null,
"name": "AKD SRL",
"address": "rue des Colonies 56 bo\u00EEte 3, 1000 Bruxelles",
"country": "BE",
"legal_form": "SRL"
},
"statutory": "statutair",
"compensated": null,
"effective_date": null,
"evidence_quote": "L\u0027administrateur a donn\u00E9 procuration, avec facult\u00E9 de substitution, \u00E0 Mme Nathalie Locht et/ou M. Timothy Speelman, \u00E9lisant domicile chez AKD SRL",
"decharge_status": null,
"mandate_duration": {
"kind": "indefinite",
"value": null
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "delegation_dagelijks_bestuur_in",
"role": "deleg\u00E9",
"person": {
"rrn": null,
"name": "Timothy Speelman",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": {
"kbo": null,
"name": "AKD SRL",
"address": "rue des Colonies 56 bo\u00EEte 3, 1000 Bruxelles",
"country": "BE",
"legal_form": "SRL"
},
"statutory": "statutair",
"compensated": null,
"effective_date": null,
"evidence_quote": "L\u0027administrateur a donn\u00E9 procuration, avec facult\u00E9 de substitution, \u00E0 Mme Nathalie Locht et/ou M. Timothy Speelman, \u00E9lisant domicile chez AKD SRL",
"decharge_status": null,
"mandate_duration": {
"kind": "indefinite",
"value": null
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "delegation_dagelijks_bestuur_in",
"role": "deleg\u00E9",
"person": {
"rrn": null,
"name": "Nathalie Locht",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": {
"kbo": null,
"name": "AKD SRL",
"address": "rue des Colonies 56 bo\u00EEte 3, 1000 Bruxelles",
"country": "BE",
"legal_form": "SRL"
},
"statutory": "statutair",
"compensated": null,
"effective_date": null,
"evidence_quote": "L\u0027actionnaire a donn\u00E9 procuration, avec facult\u00E9 de substitution, \u00E0 Mme Nathalie Locht et/ou M. Timothy Speelman, \u00E9lisant domicile chez. AKD SRL",
"decharge_status": null,
"mandate_duration": {
"kind": "indefinite",
"value": null
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "delegation_dagelijks_bestuur_in",
"role": "deleg\u00E9",
"person": {
"rrn": null,
"name": "Timothy Speelman",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": {
"kbo": null,
"name": "AKD SRL",
"address": "rue des Colonies 56 bo\u00EEte 3, 1000 Bruxelles",
"country": "BE",
"legal_form": "SRL"
},
"statutory": "statutair",
"compensated": null,
"effective_date": null,
"evidence_quote": "L\u0027actionnaire a donn\u00E9 procuration, avec facult\u00E9 de substitution, \u00E0 Mme Nathalie Locht et/ou M. Timothy Speelman, \u00E9lisant domicile chez. AKD SRL",
"decharge_status": null,
"mandate_duration": {
"kind": "indefinite",
"value": null
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2022-06-21",
"filing_date": "2022-06-13",
"act_kind_objet": "D\u00E9mission - nomination"
},
"decisions": [
{
"body": "enig_aandeelhouder_schriftelijk",
"date": "2022-06-02",
"unanimous": null
},
{
"body": "enig_aandeelhouder_schriftelijk",
"date": "2022-06-03",
"unanimous": null
}
],
"is_correction": false,
"subject_company": {
"kbo": "0737.829.015",
"name_full": "Celyntra Therapeutics",
"legal_form": "Soci\u00E9t\u00E9 anonyme",
"_kbo_filled_from_list": true
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Nathalie Locht",
"org_rep_person_name": null,
"person_role_at_subject": "Mandataire"
},
"co_filed_documents": [],
"corrected_publication_numac": null
}21-11-2019 Oprichting van een SNC
Technische details
{
"kind": "oprichting",
"seat": "6041 Gosselies, Rue Adrienne Bolland 47",
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"founders": [
{
"org": {
"kbo": "0565.979.162",
"name": "Ncardia Holding"
},
"kind": "rechtspersoon",
"person": null,
"share_class": "Ordinary",
"partner_role": null,
"holder_org_kbo": "0565.979.162",
"holder_org_name": "Ncardia Holding",
"contribution_type": "cash",
"amount_paid_in_eur": 61500.0,
"holder_person_name": null,
"is_subscriber_only": true,
"n_shares_subscribed": 100,
"amount_subscribed_eur": 61500.0,
"is_anonymous_silent_partner": false
}
],
"capital_eur": 61500.0,
"subject_company": {
"kbo": "0737.829.015",
"name_full": "CELYNTRA THERAPEUTICS",
"legal_form": "SNC"
},
"initial_directors": [],
"incorporation_date": "2019-11-07",
"post_incorporation_mandates": []
}Genereer een gestructureerde, feitelijke nota op basis van alle signalen in dit dossier: risico, financiële gezondheid, eigendomsstructuur, mandaten en sectorvergelijking.
| Officiële naamFR | CELYNTRA THERAPEUTICS |